rebimastat

DRUG4 trials

Sponsors

NCIC Clinical Trials Group, National Cancer Institute (NCI)

Conditions

Adenocarcinoma of the ProstateBone MetastasesHormone-resistant Prostate CancerLung CancerRecurrent Prostate CancerSarcomaStage IV Prostate Cancer

Phase 1

BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma

CompletedNCT00024024

National Cancer Institute (NCI)Sarcoma

Start: 2001-08-31Updated: 2013-02-11

Phase 2

Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer

CompletedNCT00039104

National Cancer Institute (NCI)Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer

Start: 2002-04-30Updated: 2013-06-05

BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

CompletedNCT00040755

National Cancer Institute (NCI)Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer +2

Start: 2002-05-31Updated: 2013-02-01

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

CompletedNCT00006229

NCIC Clinical Trials GroupLung Cancer

Start: 2000-04-04End: 2009-02-10Updated: 2020-04-06